European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 131-136, December 2008

The effect of mifepristone on apoptosis and caspase-3 activation in human ovarian luteinized granulosa cells

Women's Hospital, School of Medicine, Zhejiang University, 310006 Hangzhou, Zhejiang, China

Received 24 May 2007; received in revised form 17 April 2008; accepted 4 July 2008. published online 29 August 2008.

Abstract 

Objective

To investigate the effect of mifepristone, an oral contraceptive, on apoptosis in human ovarian luteinized granulosa cells.

Study design

Human ovarian luteinized granulosa cells were treated in vitro with 1.25, 2.5, 5.0, 10.0, or 20.0μM of mifepristone. Nuclear morphology, apoptosis ratio, and level of caspase-3 expression were determined with immunofluorescence microscopy, the terminal deoxynucleotidyl transferase mediated nick end labeling (TUNEL) assay, and flow cytometry.

Results

We found that mifepristone-treated cells contained single condensed chromatin with multiple nuclear fragments, which is morphologic evidence of apoptosis. A significant difference was observed in the TUNEL assay between mifepristone-treated cells and control cells (P<0.05). Consistent with the results of the TUNEL assay, the fluorescence intensity of caspase-3 in drug-treated cells was also significantly different (P<0.05) from control cells; specifically, the difference between cells treated with different doses of drugs was much smaller and negligible.

Conclusion

From these results, we propose that mifepristone induces human ovarian luteinized granulosa cells to undergo apoptosis by activating caspase-3.

Keywords: Mifepristone, Granulosa cells, Apoptosis, Contraception

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-2115(08)00299-6

doi:10.1016/j.ejogrb.2008.07.031

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 141, Issue 2 , Pages 131-136, December 2008